Open, randomized, multi-center phase II study comparing efficacy and tolerability of Erlotinib vs. Carboplatin/Vinorelbin in elderly patients (>70 years of age) with untreated non-small cell lung cancer

David Felix Heigener, K.-M. Deppermann, Joachim von Pawel et al. · Lung Cancer · 2014

Cited by 25 works. doi:10.1016/j.lungcan.2014.01.024

Authors

References